The Trump FDA tries to kill a therapy that has helped boys with a deadly diagnosis.

The FDA is investigating the death last month of an eight-year-old boy in Brazil who had received Sarepta Therapeutics’ Elevidys® (delandistrogene moxeparvovec-rokl)—though the company and its ...

HCA Healthcare raises 2025 profit forecast amidst insurance uncertainty while Centene anticipates a 2026 profitability boost ...

"Martir’s absence rippled beyond the school walls, touching the hearts of neighbors and strangers alike, who united in a shared hope for his safe return," Sara Myers, a spokesperson for the Torrance ...